1. Home
  2. UBSI vs LQDA Comparison

UBSI vs LQDA Comparison

Compare UBSI & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Bankshares Inc.

UBSI

United Bankshares Inc.

HOLD

Current Price

$46.49

Market Cap

6.4B

Sector

Finance

ML Signal

HOLD

LQDA

Liquidia Corporation

SELL

Current Price

$34.44

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
UBSI
LQDA
Founded
1982
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
UBSI
LQDA
Price
$46.49
$34.44
Analyst Decision
Hold
Buy
Analyst Count
6
8
Target Price
$50.33
★ $54.38
AVG Volume (30 Days)
941.0K
★ 4.6M
Earning Date
10-30-2026
11-02-2026
Dividend Yield
★ 3.26%
N/A
EPS Growth
18.91
★ 51.81
EPS
★ 1.83
1.26
Revenue
★ $311,957,000.00
$158,320,000.00
Revenue This Year
$4.25
$357.27
Revenue Next Year
$3.88
$1.34
P/E Ratio
★ $25.52
$27.38
Revenue Growth
N/A
★ 1031.18
52 Week Low
$34.68
$21.97
52 Week High
$49.62
$93.61

Technical Indicators

Market Signals
Indicator
UBSI
LQDA
Relative Strength Index (RSI) 49.96 35.01
Support Level $46.28 $32.63
Resistance Level $47.18 $42.62
Average True Range (ATR) 0.77 2.81
MACD 0.11 0.60
Stochastic Oscillator 64.80 25.40

Price Performance

Historical Comparison
UBSI
LQDA

About UBSI United Bankshares Inc.

United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which offers a full range-of-products and services through various delivery channels. Included among the banking products and services offered are the acceptance of deposits in checking, savings, time, and money market accounts; the making and servicing of personal, credit card, commercial, and floor plan loans; and the making of construction and real estate loans, as well as the origination and sale of residential mortgages in the secondary market. Also offered are trust and brokerage services, safe deposit boxes, and wire transfers.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: